India to Australia: Rivaroxaban Export Trade Route
India has recorded 57 verified shipments of Rivaroxaban exported to Australia, representing a combined trade value of $2.4M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $42.4K USD. The leading Indian exporter is TORRENT PHARMACEUTICALS LTD, which accounts for 46% of total export value with 22 shipments worth $1.1M USD. On the buying side, ARROW PHARMACEUTICALS PTY LTD. is the largest importer in Australia with $565.3K USD in purchases. The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED, LUPIN LIMITED — together control 92% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Rivaroxaban corridor is one of India's established pharmaceutical export routes, with 57 shipments documented worth a combined $2.4M USD. The route is dominated by TORRENT PHARMACEUTICALS LTD, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's rivaroxaban manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $42.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with rivaroxaban's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 12.1%, placing it at rank #9 among India's top rivaroxaban export destinations globally.
On the import side, key buyers of Indian rivaroxaban in Australia include ARROW PHARMACEUTICALS PTY LTD., ARROW PHARMACEUTICALS PTY LTD, APOTEX PTY LTD and 11 others. ARROW PHARMACEUTICALS PTY LTD. is the single largest importer with 8 shipments valued at $565.3K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ1
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#9
- Annual growth+12.1%
- Demand growth+10.8%
- Regulatory ease81/100
Top 10 Indian Rivaroxaban Exporters to Australia
Showing top 10 of 7 Indian suppliers exporting Rivaroxaban to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD Avg $50.7K per shipment | 22 | $1.1M | 46.2% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED Avg $52.6K per shipment | 17 | $894.2K | 37.0% |
| 3 | LUPIN LIMITED Avg $33.3K per shipment | 6 | $199.9K | 8.3% |
| 4 | INVENTIA HEALTHCARE LIMITED Avg $21.5K per shipment | 7 | $150.2K | 6.2% |
| 5 | DR.REDDY'S LABORATORIES LTD Avg $14.5K per shipment | 2 | $29.0K | 1.2% |
| 6 | DR REDDY S LABORATORIES LTD Avg $25.3K per shipment | 1 | $25.3K | 1.0% |
| 7 | SYNERGY TRADING Avg $273 per shipment | 2 | $546 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting rivaroxaban to Australia, ranked by total trade value. The listed exporters are: TORRENT PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED, LUPIN LIMITED, INVENTIA HEALTHCARE LIMITED, DR.REDDY'S LABORATORIES LTD, DR REDDY S LABORATORIES LTD, SYNERGY TRADING. TORRENT PHARMACEUTICALS LTD is the dominant supplier with 22 shipments worth $1.1M USD, giving it a 46% market share. The top 3 suppliers together account for 92% of the total trade value on this route.
Top 10 Rivaroxaban Importers in Australia
Showing top 10 of 14 known buyers in Australia receiving Rivaroxaban shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rivaroxaban in Australia include ARROW PHARMACEUTICALS PTY LTD., ARROW PHARMACEUTICALS PTY LTD, APOTEX PTY LTD, APOTEX PTY LTD., APOTEX PTY. LTD., among 14 total buyers. The largest importer is ARROW PHARMACEUTICALS PTY LTD., accounting for $565.3K USD across 8 shipments — representing 23% of all rivaroxaban imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ARROW PHARMACEUTICALS PTY LTD. | 8 | $565.3K | 23.4% |
| 2 | ARROW PHARMACEUTICALS PTY LTD | 11 | $421.5K | 17.5% |
| 3 | APOTEX PTY LTD | 9 | $321.7K | 13.3% |
| 4 | APOTEX PTY LTD. | 2 | $314.0K | 13.0% |
| 5 | APOTEX PTY. LTD. | 5 | $246.9K | 10.2% |
| 6 | PHARMACOR PTY LTD | 7 | $150.2K | 6.2% |
| 7 | ARROW PHARMACEUTICALS PTY LTD. . | 3 | $129.0K | 5.3% |
| 8 | GENERIC HELATH C O DHL SUPPLY CHAIN | 1 | $103.3K | 4.3% |
| 9 | GENERIC HELATH C/O DHL SUPPLY CHAIN | 4 | $78.6K | 3.3% |
| 10 | DR.REDDY S LABORATORIES (AUSTRALIA) | 2 | $29.0K | 1.2% |
Showing top 10 of 14 Rivaroxaban importers in Australia on this route.
Top 10 Rivaroxaban Formulations Imported by Australia
Showing top 10 of 45 product formulations shipped on the India to Australia Rivaroxaban route, ranked by trade value
Australia imports a wide range of rivaroxaban formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — APO-RIVAROXABAN 20MG_2X14T ARROTEX — accounts for $417.6K USD across 2 shipments. There are 45 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | APO-RIVAROXABAN 20MG_2X14T ARROTEX | 2 | $417.6K | 17.3% |
| 2 | ARX-RIVAROXABAN 20 TABLETS (RIVAROXABANTABLETS 20 MG) (NOS = 2X14 TAB.) | 3 | $230.5K | 9.5% |
| 3 | APO RIVAROXABAN 20MG 2X14T ARROTEX | 1 | $214.5K | 8.9% |
| 4 | ARX-RIVAROXABAN 20 TABLETS (RIVAROXABANTABLESTS 20 MG) (NOS = 2X14 TAB.) | 1 | $182.5K | 7.6% |
| 5 | ARX-RIVAROXABAN 15 TABLETS (RIVAROXABAN TABLETS 15 MG) (NOS = 2 X 14TAB) | 3 | $129.0K | 5.3% |
| 6 | PHARMA RIVAROXABAN TABLETS 20MG AUS GH RIVAROXABAN 20MG 1 BOX x 28 TABS | 1 | $103.3K | 4.3% |
| 7 | ARX-RIVAROXABAN 20 TABLETS(RIVAROXABAN TABLET 20MG)BSG9M003(20400 PACKS) | 2 | $93.5K | 3.9% |
| 8 | ARX-RIVAROXABAN 20 TABLETS (RIVAROXABANTABLETS 20MG)B.NO.BSG9L008/009,MFG:DEC-2024,EXP:NOV-2027 | 1 | $91.5K | 3.8% |
| 9 | ARX-RIVAROXABAN 20 TABLETS (RIVAROXABANTABLETS 20MG)B.NO.BSG9L010,MFG:DEC-2024,EXP:NOV-2027 | 2 | $90.9K | 3.8% |
| 10 | RIVOXA 20 MG (Rivaroxaban 20 mg film-coated Tablet) | 3 | $88.8K | 3.7% |
Showing top 10 of 45 Rivaroxaban formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 78%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 12 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's rivaroxaban exports to Australia are driven primarily by a handful of large-scale manufacturers. TORRENT PHARMACEUTICALS LTD with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED, LUPIN LIMITED — together account for 92% of total trade value on this route. The average shipment value of $42.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as arx-rivaroxaban 20 tablets (rivaroxabantablets 20 mg) (nos = 2x14 tab.) and apo rivaroxaban 20mg 2x14t arrotex, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ARROW PHARMACEUTICALS PTY LTD. is the largest importer with 8 shipments worth $565.3K USD — representing 23% of all rivaroxaban imports from India on this route. A total of 14 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.4M
- Avg. Shipment
- $42.4K
- Suppliers
- 7
- Buyers
- 14
- Transit (Sea)
- ~15 days
- Annual Growth
- +12.1%
Related Analysis
Reverse Direction
Australia → India — Rivaroxaban (Import)Other Rivaroxaban Routes
Unlock the Full India to Australia Rivaroxaban Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 57 shipments on this route.
Frequently Asked Questions — India to Australia Rivaroxaban Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rivaroxaban to Australia?
The leading Indian exporters of Rivaroxaban to Australia are TORRENT PHARMACEUTICALS LTD, ALEMBIC PHARMACEUTICALS LIMITED, LUPIN LIMITED. TORRENT PHARMACEUTICALS LTD holds the largest market share at approximately 46% of total trade value on this route.
Q What is the total value of Rivaroxaban exports from India to Australia?
India exports Rivaroxaban to Australia worth approximately $2.4M USD across 57 recorded shipments. The average value per shipment is $42.4K USD.
Q Which ports does India use to ship Rivaroxaban to Australia?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 12 shipments. Indian exporters primarily use sea freight for this route, with 78% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Australia for Rivaroxaban?
The average transit time for Rivaroxaban shipments from India to Australia is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Australia Rivaroxaban trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.1% with demand growth tracking at 10.8%. The route is ranked #9 among India's top Rivaroxaban export destinations globally.
Q How many suppliers are active on the India to Australia Rivaroxaban route?
There are currently 7 active Indian suppliers exporting Rivaroxaban to Australia. The market is moderately concentrated with TORRENT PHARMACEUTICALS LTD accounting for 46% of total shipment value.
Q Who are the main importers of Rivaroxaban from India in Australia?
The leading importers of Indian Rivaroxaban in Australia include ARROW PHARMACEUTICALS PTY LTD., ARROW PHARMACEUTICALS PTY LTD, APOTEX PTY LTD, APOTEX PTY LTD., APOTEX PTY. LTD.. ARROW PHARMACEUTICALS PTY LTD. is the largest buyer with 8 shipments worth $565.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Rivaroxaban.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 14 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 57 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
57 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists